[Adduction spastic dysphonia: clinical and treatment].
Adduction spastic dystonia (SD) is currently considered a focal dystonia involving laryngeal muscles. SD is one of the most poorly known focal dystonias. We reviewed our experience with twentynine patients with adduction SD and compared the clinical and epidemiologic variables with the other focal dystonias studied at our institution in the last five years (132 patients). Mean age of patients (47.2 +/- 13 years), sex, clinical course in years (5.7 +/- 5) and presence of circadian fluctuations did not differ significantly from those observed in patients with other focal dystonias. Likewise, there were no significant differences regarding the presence of a family history of dystonia, essential tremor, or stuttering. Our results confirm the similarity of the clinical and epidemiologic data of SD with the other focal dystonias. All patients with SD were treated with a local injection of botulinum toxin. A total of 108 treatments were performed, 41 with a visually guided transoral technique and 67 with a percutaneous technique. The transoral technique was effective in all cases (41/41) but not all treatments with the percutaneous technique were effective (53/67). Three patients required the shift to the transoral procedure to achieve enough symptomatic alleviation.
García Ruiz
P J
PJ
Servicio de Neurología, Fundación Jiménez Díaz, Madrid.
Sánchez del Río
M
M
Cenjor Español
C
C
Sanabria Brassart
J
J
Sánchez Bernardos
V
V
Astarloa Gómez
R
R
García de Yébenes
J
J
D000328:Adult; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D001905:Botulinum Toxins / Q000627:therapeutic use; D004421:Dystonia / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014832:Voice Disorders / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins
Disfonía espástica de aducción: clínica y tratamiento.